Back to search

University of Patras

Γονιδιακή θεραπεία μυοκαρδιοπαθειών: στοχεύοντας το οξειδωτικό στρες

Abstract

dc:description

Recent studies support the contribution of oxidative stress in the development cardiovascular diseases. Oxidative stress has been strongly linked to cell death and cardiac remodeling processes, all hallmarks of heart failure. Mice null for desmin, which is the major muscle specific intermediate filament protein, develop dilated cardiomyopathy and heart failure characterized by mitochondrial defects and cardiomyocyte death accompanied by extensive calcification and fibrosis, thus providing a very good model for heart failure. Several cellular and biochemical alterations in the hearts of these mice strongly suggested that oxidative stress is one of mechanisms contributing to the pathogenesis of the phenotype. The defects in mitochondrial structure and function, hallmarks of the desmin null mouse phenotype, provide the most important indications for the existence of oxidative stress, as the respiratory chain is the most important source of reactive oxygen species (ROS) in cardiomyocytes. In order to delineate the existence of oxidative stress in the desmin null myocardium and therefore its participation in the development of the myocardial degeneration we sought both in vitro and in vivo approaches. The existence of oxidative stress was addressed in primary adult cardiomyocytes. The reinforcement of antioxidant defense system was pursued, in order to assess the contribution of oxidative stress in the myocardial degeneration, as well as the therapeutic potential of antioxidant strategies. To assess intracellular oxidative stress a new method for the isolation of adult mouse cardiomyocytes was developed. Since mitochondria were the target of pathology, we wanted to first determine global changes in the mitochondrial proteome. The observed changes in protein levels reinforced the original hypothesis. Intracellular reactive oxygen species were measured using fluorescent probes in adult cardiomyocyte cultures. Analysis of the above data showed that there are increased levels of ROS in desmin null cardiomyocytes. Furthermore, the mitochondrial membrane potential, which is indicative of proper mitochondrial function, was investigated using a fluorescent probe. It was found altered in a subset of the desmin null cardiomyocytes. In order to (1) verify the existence of oxidative stress in vivo, (2) assess its contribution to the phenotype of desmin null mice and (3) evaluate the therapeutic 5 potential of protecting against it, the antioxidant defense system was fortified in vivo using the desmin null mouse as a heart failure model. Towards this goal transgenic mice overexpressing the antioxidant genes catalase and manganese superoxide dismutase (MnSOD) were created.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Rapti, Kleopatra
  • Ράπτη, Κλεοπάτρα

Subjects

dc:subject × 17

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/17604

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Rapti, Kleopatra; Ράπτη, Κλεοπάτρα. Γονιδιακή θεραπεία μυοκαρδιοπαθειών: στοχεύοντας το οξειδωτικό στρες. University of Patras, 2008. http://hdl.handle.net/10442/hedi/17604